Functional analysis of a tripartite stability element within the CD40 ligand 3' untranslated region

Immunology
Jennifer LaughlinLori R Covey

Abstract

We previously identified a cis-acting element within the 3' untranslated region of CD40 ligand messenger RNA (mRNA) that is composed of three complex binding sites and acts to increase mRNA stability in both in vitro and in vivo systems. We now demonstrate the functional consequences of the three binding sites with respect to increasing both luciferase activity and mRNA stability in a heterologous transcript expressed in a T-cell line. The internal region B was shown to be a bona fide stability element because its presence increased luciferase activity fourfold over the unmodified transcript and its removal from the XbaI-HaeIII region resulted in rapid degradation of the transcript. Region A contained both a binding site for a polypyrimidine-tract-binding protein (PTB)-mediated complex (Complex I) and an upstream, adjacent sequence that was a negative regulator of mRNA stability. Region C bound Complex II, which contained both PTB and heterogeneous nuclear ribonucleoproteinL (hnRNPL), and was less effective as a stability element on its own compared to region B. Our findings demonstrate differential levels of activity for the three binding sites relative to the turnover of CD40 ligand mRNA, suggesting that the lack of binding o...Continue Reading

References

Apr 1, 1993·European Journal of Immunology·P HermannJ P Galizzi
Mar 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·R FuleihanR S Geha
Aug 1, 1994·Immunity·J XuR A Flavell
Mar 1, 1994·The Journal of Clinical Investigation·R FuleihanR S Geha
Apr 1, 1996·European Journal of Immunology·H G NüssleinB Manger
May 1, 1996·Immunity·R J Noelle
Jan 1, 1996·Annual Review of Immunology·T M FoyR J Noelle
Nov 26, 1996·Proceedings of the National Academy of Sciences of the United States of America·W W HancockL A Turka
Aug 5, 1997·Proceedings of the National Academy of Sciences of the United States of America·A D KirkS J Knechtle
May 1, 1998·FEBS Letters·B HahmS K Jang
May 23, 1998·Annual Review of Immunology·I S Grewal, R A Flavell
Oct 18, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·B BarnhartL R Covey
Feb 13, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·E ParraD Mercola
Mar 20, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·H LindgrenT Leanderson
Sep 1, 2001·Clinical and Experimental Immunology·M SrahnaP Vandenberghe
Dec 26, 2001·The Journal of Biological Chemistry·Lisa A SchubertDavid B Lewis
Feb 16, 2002·Methods : a Companion to Methods in Enzymology·K J Livak, T D Schmittgen
Jan 2, 2003·Molecular and Cellular Biology·B JoNell HamiltonWilliam F C Rigby
Jan 9, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Penelope A KosinskiLori R Covey
Jul 9, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Karnail SinghLori R Covey

❮ Previous
Next ❯

Citations

Jul 3, 2009·European Journal of Immunology·Stefano VavassoriLori R Covey
May 26, 2021·The Journal of Immunology : Official Journal of the American Association of Immunologists·Bitha NarayananLori R Covey

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.